Status
Conditions
Treatments
About
This study looks to gather data on hepatomiR, a CE-certified test already intended for gauging liver-related outcomes, in order to define a cut-off regarding specific decompensation events (ascites, variceal hemorrhage, hepatic encephalopathy) in chronic liver disease (CLD). Based on these data, it is aimed to advance the current understanding of factors driving decompensation, with potential repercussions for future risk management and therapy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
156 participants in 1 patient group
Loading...
Central trial contact
Lukas Erhart, Mag. Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal